Carregant...
Choosing Alzheimer’s disease prevention clinical trial populations
To assist investigators in making design choices, we modeled Alzheimer’s disease (AD) prevention clinical trials. We used longitudinal Clinical Dementia Rating Scale Sum of the Boxes data, retention rates, and the proportions of trial eligible cognitively normal participants age 65 and older in the...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3864603/ https://ncbi.nlm.nih.gov/pubmed/24119546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2013.09.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|